EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of Computational In Silico Model for Nano Lipid Carrier Formulation of Curcumin

Omar Waleed Abduljaleel Albasri, Palanirajan Vijayaraj Kumar iD, Mogana Sundari Rajagopal iD

Molecules · 15.02.2023 · 28 (4) · 1833

DOI: 10.3390/molecules28041833 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 15.02.2023. Verfasst von Omar Waleed Abduljaleel Albasri und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, Department of Pharmaceutical Technology, UCSI University, Jalan Menara Gading, Taman Connaught, Cheras, Kuala Lum…. Hauptthemen laut MEDLINE: Curcumin, COVID-19, Nanostructures. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Grant Scheme (FRGS), Ministry of Higher Education (MOHE), Centre of Excellence in Research, Value Innovation, and Entrepreneurship (CERVIE), UCSI University, Malaysia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The oral delivery system is very important and plays a significant role in increasing the solubility of drugs, which eventually will increase their absorption by the digestive system and enhance the drug bioactivity. This study was conducted to synthesize a novel curcumin nano lipid carrier (NLC) and use it as a drug carrier with the help of computational molecular docking to investigate its solubility in different solid and liquid lipids to choose the optimum lipids candidate for the NLCs formulation and avoid the ordinary methods that consume more time, materials, cost, and efforts during laboratory experiments. The antiviral activity of the formed curcumin–NLC against SARS-CoV-2 (COVID-19) was assessed through a molecular docking study of curcumin’s affinity towards the host cell receptors. The novel curcumin drug carrier was synthesized as NLC using a hot and high-pressure homogenization method. Twenty different compositions of the drug carrier (curcumin nano lipid) were synthesized and characterized using different physicochemical techniques such as UV–Vis, FTIR, DSC, XRD, particle size, the zeta potential, and AFM. The in vitro and ex vivo studies were also conducted to test the solubility and the permeability of the 20 curcumin–NLC formulations. The NLC as a drug carrier shows an enormous enhancement in the solubility and permeability of the drug.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminCOVID-19NanostructuresHumansLipidsMolecular Docking SimulationSARS-CoV-2Drug CarriersParticle Size

Stichwörter der Autor:innen

NLCsSLNscurcumindrug carriermolecular dockingpermeability

Substanzen

CurcuminLipidsDrug Carriers

Autor:innen und Institutionen

  • Faculty of Pharmaceutical Sciences, Department of Pharmaceutical Technology, UCSI University, Jalan Menara Gading, Taman Connaught, Cheras, Kuala Lumpur 56000, Malaysia.

ORCID-Profile: Palanirajan Vijayaraj Kumar, Mogana Sundari Rajagopal

Förderung

  • Fundamental Research Grant Scheme (FRGS)
  • Ministry of Higher Education (MOHE)
  • Centre of Excellence in Research, Value Innovation, and Entrepreneurship (CERVIE), UCSI University, Malaysia

Zitieren

APA

Albasri, O. W. A., Kumar, P. V., & Rajagopal, M. S. (2023). Development of Computational In Silico Model for Nano Lipid Carrier Formulation of Curcumin. Molecules, 28(4), 1833. https://doi.org/10.3390/molecules28041833

Vancouver

Albasri OWA, Kumar PV, Rajagopal MS. Development of Computational In Silico Model for Nano Lipid Carrier Formulation of Curcumin. Molecules. 2023;28(4):1833. doi:10.3390/molecules28041833

BibTeX
@article{Albasri2023,
  author = {Albasri, Omar Waleed Abduljaleel and Kumar, Palanirajan Vijayaraj and Rajagopal, Mogana Sundari},
  title = {Development of Computational In Silico Model for Nano Lipid Carrier Formulation of Curcumin},
  journal = {Molecules},
  year = {2023},
  volume = {28},
  number = {4},
  pages = {1833},
  doi = {10.3390/molecules28041833}
}
Kostenlos starten →